Phathom Pharmaceuticals Inc (NASDAQ: PHAT) on Tuesday, soared 4.09% from the previous trading day, before settling in for the closing price of $14.41. Within the past 52 weeks, PHAT’s price has moved between $2.21 and $16.08.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.50%. The company achieved an average annual earnings per share of 40.34%. With a float of $41.32 million, this company’s outstanding shares have now reached $71.04 million.
Phathom Pharmaceuticals Inc (PHAT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Phathom Pharmaceuticals Inc is 41.92%, while institutional ownership is 50.78%. The most recent insider transaction that took place on Nov 03 ’25, was worth 7,079. In this transaction Principal Accounting Officer of this company sold 524 shares at a rate of $13.51, taking the stock ownership to the 47,407 shares. Before that another transaction happened on Sep 05 ’25, when Company’s Principal Accounting Officer sold 461 for $12.09, making the entire transaction worth $5,573. This insider now owns 47,931 shares in total.
Phathom Pharmaceuticals Inc (PHAT) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.05 earnings per share (EPS) for the period topping the consensus outlook (set at -1.08) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.34% per share during the next fiscal year.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Phathom Pharmaceuticals Inc (PHAT) is currently performing well based on its current performance indicators. A quick ratio of 2.19 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -0.73 in one year’s time.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
The latest stats from [Phathom Pharmaceuticals Inc, PHAT] show that its last 5-days average volume of 1.01 million was inferior to 1.6 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.01%.
During the past 100 days, Phathom Pharmaceuticals Inc’s (PHAT) raw stochastic average was set at 87.25%, which indicates a significant increase from 71.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.09 in the past 14 days, which was higher than the 0.80 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.74, while its 200-day Moving Average is $8.44. Now, the first resistance to watch is $15.48. This is followed by the second major resistance level at $15.96. The third major resistance level sits at $16.64. If the price goes on to break the first support level at $14.32, it is likely to go to the next support level at $13.64. The third support level lies at $13.16 if the price breaches the second support level.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Key Stats
Market capitalization of the company is 1.07 billion based on 71,138K outstanding shares. Right now, sales total 55,250 K and income totals -334,330 K. The company made 49,500 K in profit during its latest quarter, and -29,970 K in sales during its previous quarter.
